发明名称 Compositions and methods for inhibiting expression of the ALAS1 gene
摘要 The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1.
申请公布号 US9133461(B2) 申请公布日期 2015.09.15
申请号 US201313835613 申请日期 2013.03.15
申请人 Alnylam Pharmaceuticals, Inc.;Icahn School of Medicine at Mount Sinai 发明人 Bettencourt Brian;Fitzgerald Kevin;Querbes William;Desnick Robert J.;Yasuda Makiko
分类号 C12N15/113;A61K31/713 主分类号 C12N15/113
代理机构 Lando & Anastasi, LLP 代理人 Lando & Anastasi, LLP
主权项 1. A double-stranded ribonucleic acid (dsRNA) for inhibiting expression of ALAS1, wherein said dsRNA comprises a sense strand and an antisense strand, wherein: (i) the antisense strand is complementary to at least nucleotides 871-889 of SEQ ID NO:1 and comprises SEQ ID NO:1296, (ii) the sense strand comprises at least 15 contiguous nucleotides from SEQ ID NO:1295, (iii) a ligand and linker with a structure as shown below is attached to the 3′ end of the sense strand of the dsRNAand (iv) the dsRNA comprises one or more nucleotides with a modification chosen from a 2′-O-methyl modified nucleotide, a 2′-fluoro modified nucleotide, or both.
地址 Cambridge MA US